Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation

Dexmedetomidine (DEX) is an anesthetic that is widely used in the clinic, and it has been reported to exhibit paradoxical effects in the progression of multiple solid tumors. In this study, we sought to explore the mechanism by which DEX regulates hepatocellular carcinoma (HCC) progression underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peng, Luo, Xiaojun, Dai, Guanqi, Jiang, Yuchuan, Luo, Yue, Peng, Shuang, Wang, Hao, Xie, Penghui, Qu, Chen, Lin, Wenyu, Hong, Jian, Ning, Xue, Li, Aimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080602/
https://www.ncbi.nlm.nih.gov/pubmed/32632241
http://dx.doi.org/10.1038/s12276-020-0461-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080602/
https://www.ncbi.nlm.nih.gov/pubmed/32632241
http://dx.doi.org/10.1038/s12276-020-0461-6

Ejemplares similares